[Opinions of Experts from China Pharmaceutical Network] Recently, 7 academicians from home and abroad, through keynote speeches and theme discussions, discussed the development opportunities and paths of biomedicine under the background of the Guangdong-Hong Kong-Macao Greater Bay Area and discussed the development of the biomedical industry. In the future, we will actively provide advice and suggestions for the development of the biomedical industry in Pingshan District.

The "regeneration technology" brought by Academician Cato Laurentson has attracted a lot of attention.

★Academician of the National Academy of Engineering-Cato T. Laurencin

Academician of the American Academy of Engineering, Medical School, Third World Academy of Sciences, and foreign academician of the Chinese Academy of Engineering. Received a doctorate in medicine from Harvard University in 1987. He is a world-renowned biomaterial science and engineering expert, orthopedic surgeon, and founder of regenerative engineering.

"My research is mainly in the field of regenerative cells and stem cells. I hope that living cells can be reprogrammed and used to restore injured tissues to their existing functions. This technology has won the international medical Oscar known as the American medical profession. prize.

Whether it is translational medicine or regenerative engineering, it is a new way of thinking that connects basic medical research and clinical treatment. Shenzhen has shown great momentum in this regard. The government is investing heavily in biomedical research and strives to become A leader in the global field, and the various advantages and conditions that Pingshan has, I finally made a choice. "

★Academician of Chinese Academy of Engineering——Ding Jian

Tumor pharmacologist, graduated from Kyushu National University in Japan with a doctorate degree in 1992. He was elected as an academician of the Chinese Academy of Engineering in 2009 and is currently the dean of the School of Pharmacy, University of Chinese Academy of Sciences.

"To be truly innovative, we must pay attention to basic research. Shenzhen is already at the forefront of the country in this regard. For Pingshan, we can start by building a government-supported public platform to continuously improve various functions, including biological drugs and Basic testing of technology, as well as some large-scale scientific research instruments, allow companies to meet various R&D needs in Pingshan, which is also conducive to attracting companies to settle down and help companies grow."

★Academician of the Chinese Academy of Sciences——Yan Deyue

Polymer chemist, professor at Shanghai Jiaotong University, received a PhD in natural science from Catholic University of Leuven, Belgium in 2002, and was elected as an academician of the Chinese Academy of Sciences in 2005.

"Chemotherapy is currently the most effective way to treat cancer, but it also has some shortcomings and problems, such as easy induction of drug resistance and strong side effects. For this reason, we proposed the concept of small molecule nanomedicine and conducted animal experiments. Some results have been achieved, and the next step is to strive to move to the clinic as soon as possible, hoping to establish a platform for transformation in Pingshan."

★Academician of the Chinese Academy of Sciences——Zhang Xuemin

Received a doctorate degree from the Academy of Military Medical Sciences in 1995. He successively served as the chief scientist of the national major scientific research project and the academic leader of the "Tumor Biology" innovative research group of the National Foundation of China.

"Nowadays, there are no particularly effective drugs for some major diseases, and we can only try to solve them through innovation. In this regard, Shenzhen has obvious advantages. As Shenzhen continues to increase mechanism innovation and improve innovation policies, it cannot be done and cannot be done elsewhere. , If you do it slowly, you can speed up the clinical experience when you come to Shenzhen."

★Academician of the National Academy of Engineering——Sun Yongkui

In 1983, he went to the California Institute of Technology to study and obtained a Ph.D. in chemistry. He was awarded the AstraZeneca Green Chemistry and Engineering Excellence Award from the British Association of Chemical Engineers and the President's Green Chemistry Challenge Award. In 2016, he was elected as a member of the American Academy of Engineering.

“The research and development of new drugs requires a variety of basic scientific support and an excellent research and development ecological environment. I think the research and development environment can be solved by establishing a large platform to shorten the time period, accelerate the development of new drugs, and attract some innovative talents. Let them focus on the development of their own fields."

★Academician of the Royal Society of Chemistry-Zhao Xiaobin

Ph.D. in Medical Materials, Institute of Polymer Research, Nankai University, Ph.D., Department of Bioengineering, Biomaterials and Artificial Instruments, University of Strathclyde, UK. He is currently a Fellow of the Royal Society of Chemistry and a Chartered Chemist.

"The development of the Pingshan National Biomedical Base can learn from Australia's practices and actively introduce high-quality projects from outside, which can reduce costs and increase the success rate after entering the market, thereby accelerating the growth and development of the base."

★Academician of the French National Academy of Technology-Han Zhongchao

Professor of Nankai University School of Medicine, doctoral supervisor, and head of the Institute of Hematology, Chinese Academy of Medical Sciences and Peking Union Medical College, and was elected as a foreign academician of the French Academy of Medical Sciences in 2006.

"Stem cells and immune cells have created a new therapeutic approach or treatment method, and opened up a brand-new therapeutic effect for some diseases that are difficult to cure by medicine. Stem cell regenerative medicine, coupled with immune cells, will be a revolution in medicine. Pingshan should pay attention to the introduction of such scientific research institutions and enterprises with very large clinical application prospects."

Original title: The collision of passion and ideas explores the future of the biomedical industry

teaches you the whole process of using APP (Pharmaceutical Link) to seize the business opportunity of medicine

(Source: Shenzhen Special Zone News)